Financial Ratios China Petroleum & Chemical Corporation
Equities
386
CNE1000002Q2
Oil & Gas Refining and Marketing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.950 HKD | +3.34% |
|
+7.14% | +6.00% |
| 09/01 | Sinopec, China National Aviation Fuel Group to Restructure | MT |
| 08/01 | Sinopec and China National Aviation Fuel Group to conduct reorganization | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.51 | 3.72 | 2.68 | 2.69 | 2.07 | |||||
Return on Total Capital | 0.75 | 5.58 | 4.07 | 3.98 | 2.99 | |||||
Return On Equity % | 4.76 | 9.55 | 8.17 | 7.16 | 5.83 | |||||
Return on Common Equity | 4.47 | 9.5 | 8.49 | 7.33 | 6.05 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.27 | 24.2 | 19.06 | 19.98 | 20.33 | |||||
SG&A Margin | 6.71 | 5.78 | 4.81 | 5.22 | 5.46 | |||||
EBITDA Margin % | 5.25 | 7.54 | 5.26 | 5.66 | 5.5 | |||||
EBITA Margin % | 0.79 | 4.03 | 2.55 | 2.74 | 2.29 | |||||
EBIT Margin % | 0.68 | 3.93 | 2.48 | 2.67 | 2.21 | |||||
Income From Continuing Operations Margin % | 1.99 | 3.13 | 2.28 | 2.11 | 1.83 | |||||
Net Income Margin % | 1.57 | 2.63 | 1.99 | 1.82 | 1.59 | |||||
Net Avail. For Common Margin % | 1.57 | 2.63 | 1.99 | 1.82 | 1.59 | |||||
Normalized Net Income Margin | 1.04 | 2.28 | 1.61 | 1.31 | 1.12 | |||||
Levered Free Cash Flow Margin | 1.21 | 2.56 | -2.01 | -1.06 | 0.29 | |||||
Unlevered Free Cash Flow Margin | 1.67 | 2.9 | -1.69 | -0.71 | 0.67 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.2 | 1.51 | 1.73 | 1.62 | 1.5 | |||||
Fixed Assets Turnover | 2.06 | 2.73 | 3.14 | 2.88 | 2.65 | |||||
Receivables Turnover (Average Receivables) | 38.18 | 62.96 | 71.85 | 62.47 | 61.65 | |||||
Inventory Turnover (Average Inventory) | 9.21 | 11.56 | 11.89 | 10.38 | 9.65 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.87 | 0.87 | 0.78 | 0.83 | 0.78 | |||||
Quick Ratio | 0.51 | 0.5 | 0.37 | 0.37 | 0.34 | |||||
Operating Cash Flow to Current Liabilities | 0.32 | 0.35 | 0.17 | 0.25 | 0.22 | |||||
Days Sales Outstanding (Average Receivables) | 9.59 | 5.8 | 5.08 | 5.84 | 5.94 | |||||
Days Outstanding Inventory (Average Inventory) | 39.72 | 31.58 | 30.7 | 35.17 | 37.91 | |||||
Average Days Payable Outstanding | 42.65 | 32.29 | 32.53 | 37.44 | 38.43 | |||||
Cash Conversion Cycle (Average Days) | 6.66 | 5.08 | 3.26 | 3.58 | 5.42 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 34.03 | 34.48 | 38.1 | 46.06 | 48.93 | |||||
Total Debt / Total Capital | 25.39 | 25.64 | 27.59 | 31.53 | 32.86 | |||||
LT Debt/Equity | 29.01 | 28.66 | 29.31 | 36.8 | 37.59 | |||||
Long-Term Debt / Total Capital | 21.64 | 21.31 | 21.22 | 25.19 | 25.24 | |||||
Total Liabilities / Total Assets | 49.08 | 51.56 | 51.95 | 52.79 | 53.29 | |||||
EBIT / Interest Expense | 0.94 | 7.17 | 4.9 | 4.74 | 3.66 | |||||
EBITDA / Interest Expense | 8.29 | 14.88 | 11.46 | 11.08 | 10.16 | |||||
(EBITDA - Capex) / Interest Expense | -0.34 | 5.23 | 1.17 | 1.59 | 2.67 | |||||
Total Debt / EBITDA | 2.38 | 1.41 | 1.86 | 2.2 | 2.52 | |||||
Net Debt / EBITDA | 0.89 | 0.42 | 1.1 | 1.38 | 1.75 | |||||
Total Debt / (EBITDA - Capex) | -58.08 | 4.02 | 18.19 | 15.33 | 9.57 | |||||
Net Debt / (EBITDA - Capex) | -21.73 | 1.19 | 10.8 | 9.63 | 6.64 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -28.85 | 30.15 | 21.08 | -3.2 | -4.29 | |||||
Gross Profit, 1 Yr. Growth % | -13.12 | 29.77 | -4.62 | 1.46 | -2.78 | |||||
EBITDA, 1 Yr. Growth % | -37.3 | 87.09 | -15.49 | 4.07 | -5.04 | |||||
EBITA, 1 Yr. Growth % | -80.21 | 562.13 | -23.45 | 7.55 | -16.73 | |||||
EBIT, 1 Yr. Growth % | -82.53 | 652.69 | -23.67 | 7.83 | -17.13 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -41.84 | 104.78 | -11.89 | -11.29 | -17.22 | |||||
Net Income, 1 Yr. Growth % | -42.43 | 117.47 | -8.09 | -12.88 | -16.07 | |||||
Normalized Net Income, 1 Yr. Growth % | -43.51 | 184.78 | -14.45 | -18.39 | -14.1 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -42.51 | 117.58 | -7.91 | -12.1 | -16.99 | |||||
Accounts Receivable, 1 Yr. Growth % | -29.69 | -7.95 | 22.23 | 2.01 | -7.72 | |||||
Inventory, 1 Yr. Growth % | -21.76 | 36.56 | 17.74 | 2.73 | 2.27 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -8.16 | 4.38 | 6.68 | 3.99 | 4.09 | |||||
Total Assets, 1 Yr. Growth % | -1.5 | 8.97 | 3.14 | 3.77 | 2.8 | |||||
Tangible Book Value, 1 Yr. Growth % | 0.69 | 4.97 | 1.95 | 2.28 | 1.94 | |||||
Common Equity, 1 Yr. Growth % | 0.34 | 4.41 | 1.36 | 1.95 | 1.6 | |||||
Cash From Operations, 1 Yr. Growth % | 9.05 | 34.42 | -48.36 | 38.88 | -7.5 | |||||
Capital Expenditures, 1 Yr. Growth % | -7.32 | 10.47 | 19.05 | -0.6 | -18.83 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -231.66 | 174.36 | -195.11 | -48.23 | -124.61 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -501.47 | 126.81 | -170.7 | -58.86 | -182.43 | |||||
Dividend Per Share, 1 Yr. Growth % | -58.06 | 261.54 | -24.47 | -2.82 | -17.1 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -14.66 | -3.77 | 25.53 | 8.26 | -3.72 | |||||
Gross Profit, 2 Yr. CAGR % | -7.51 | 6.18 | 11.25 | -1.63 | -0.57 | |||||
EBITDA, 2 Yr. CAGR % | -24.31 | 8.31 | 25.74 | -6.22 | -1.56 | |||||
EBITA, 2 Yr. CAGR % | -54.84 | 14.48 | 125.13 | -10.76 | -7.29 | |||||
EBIT, 2 Yr. CAGR % | -57.37 | 14.69 | 139.69 | -10.81 | -7.44 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -27.1 | 9.13 | 34.32 | -11.09 | -14.31 | |||||
Net Income, 2 Yr. CAGR % | -26.71 | 11.89 | 41.38 | -9.99 | -14.49 | |||||
Normalized Net Income, 2 Yr. CAGR % | -28.09 | 26.83 | 56.09 | -17.86 | -18.49 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -26.76 | 11.84 | 41.55 | -9.48 | -14.58 | |||||
Accounts Receivable, 2 Yr. CAGR % | -17.35 | -19.55 | 6.08 | 11.66 | -2.98 | |||||
Inventory, 2 Yr. CAGR % | -9.29 | 3.37 | 26.81 | 9.98 | 2.5 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.97 | -2.09 | 5.52 | 5.33 | 4.04 | |||||
Total Assets, 2 Yr. CAGR % | 4.35 | 3.6 | 6.01 | 3.52 | 3.29 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.01 | 2.81 | 3.45 | 2.31 | 2.11 | |||||
Common Equity, 2 Yr. CAGR % | 1.67 | 2.36 | 2.87 | 1.84 | 1.78 | |||||
Cash From Operations, 2 Yr. CAGR % | -2.4 | 21.07 | -16.69 | -15.32 | 13.34 | |||||
Capital Expenditures, 2 Yr. CAGR % | 12.85 | 1.18 | 14.68 | 8.78 | -10.17 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -35.93 | 90.06 | 61.54 | -30.37 | -63.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -27.58 | 201.76 | 26.63 | -46.57 | -39 | |||||
Dividend Per Share, 2 Yr. CAGR % | -44.37 | 23.13 | 65.25 | -14.32 | -10.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -3.73 | -1.77 | 3.88 | 15.11 | 3.92 | |||||
Gross Profit, 3 Yr. CAGR % | -4.63 | 3.54 | 2.45 | 7.89 | -1.94 | |||||
EBITDA, 3 Yr. CAGR % | -17.82 | 2.34 | -0.29 | 18.05 | -6.45 | |||||
EBITA, 3 Yr. CAGR % | -41 | 10.54 | 0.11 | 74.06 | -13.98 | |||||
EBIT, 3 Yr. CAGR % | -42.89 | 11.01 | 0.13 | 81.59 | -14.18 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -15.87 | 2.86 | 1.62 | 17.42 | -13.18 | |||||
Net Income, 3 Yr. CAGR % | -13.56 | 5.32 | 4.79 | 20.78 | -12.07 | |||||
Normalized Net Income, 3 Yr. CAGR % | -16.97 | 13.78 | 11.23 | 24.32 | -18.11 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -13.6 | 5.29 | 4.83 | 21.25 | -12.06 | |||||
Accounts Receivable, 3 Yr. CAGR % | -19.42 | -14.33 | -7.51 | 4.7 | 4.79 | |||||
Inventory, 3 Yr. CAGR % | -6.64 | 3.97 | 7.95 | 18.21 | 7.35 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.41 | 10.68 | 0.75 | 5.01 | 4.91 | |||||
Total Assets, 3 Yr. CAGR % | 2.81 | 5.87 | 3.45 | 5.31 | 3.28 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.86 | 2.99 | 2.52 | 3.19 | 2.19 | |||||
Common Equity, 3 Yr. CAGR % | 0.7 | 2.58 | 2.02 | 2.69 | 1.76 | |||||
Cash From Operations, 3 Yr. CAGR % | -4.27 | 8.59 | -8.87 | -1.22 | -12.79 | |||||
Capital Expenditures, 3 Yr. CAGR % | 22.74 | 12.05 | 6.82 | 9.34 | -1.33 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -43.51 | 4.04 | 50.89 | 9.98 | -49.73 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -37.88 | 5.95 | 86.03 | -13.48 | -36.32 | |||||
Dividend Per Share, 3 Yr. CAGR % | -36.18 | 3.82 | 4.62 | 38.45 | -15.26 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.83 | 7.26 | 7.05 | 2.13 | 0.77 | |||||
Gross Profit, 5 Yr. CAGR % | -0.56 | 3.79 | 1.43 | 1.44 | 1.23 | |||||
EBITDA, 5 Yr. CAGR % | -7.05 | 2.66 | -2.58 | -1.18 | -0.8 | |||||
EBITA, 5 Yr. CAGR % | -22.18 | 10.93 | 0.81 | 1.47 | -3.56 | |||||
EBIT, 5 Yr. CAGR % | -24.53 | 10.99 | 1.36 | 1.71 | -3.63 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -0.87 | 7.63 | 1.44 | -2.97 | -4.86 | |||||
Net Income, 5 Yr. CAGR % | 0.36 | 9.05 | 5.24 | -1.1 | -3.17 | |||||
Normalized Net Income, 5 Yr. CAGR % | -2.55 | 16.57 | 6.88 | -0.13 | -2.45 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.3 | 9.03 | 5.26 | -0.89 | -3.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | -7.96 | -8.46 | -10.05 | -4.75 | -5.72 | |||||
Inventory, 5 Yr. CAGR % | 0.85 | 5.8 | 5.52 | 6.33 | 5.74 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.05 | 4.52 | 7.25 | 8.51 | 2.05 | |||||
Total Assets, 5 Yr. CAGR % | 3.68 | 4.74 | 4.08 | 4.92 | 3.41 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.72 | 1.66 | 1.89 | 2.72 | 2.44 | |||||
Common Equity, 5 Yr. CAGR % | 1.86 | 1.72 | 1.56 | 2.28 | 2 | |||||
Cash From Operations, 5 Yr. CAGR % | 0.21 | 0.97 | -9.44 | -1.69 | -0.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | 5.02 | 14.75 | 19.45 | 10.73 | -0.33 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -7 | -12.66 | -14 | -11.4 | -14.43 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -3.47 | -11.17 | -17.4 | -19.43 | 18.65 | |||||
Dividend Per Share, 5 Yr. CAGR % | -2.82 | 13.55 | -6.62 | -3.86 | -1.6 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















